Services on Demand
- Cited by Google
- Similars in SciELO
- Similars in Google
Arquivos Brasileiros de Endocrinologia & Metabologia
Print version ISSN 0004-2730
ROLLIN, Guilherme; PUNALES, Márcia; GEREMIA, César and CE, Gislaine Vissoky. Use of insulin glargine in type 1 diabetes children with less than eight years old. Arq Bras Endocrinol Metab [online]. 2009, vol.53, n.6, pp. 721-725. ISSN 0004-2730. http://dx.doi.org/10.1590/S0004-27302009000600005.
OBJECTIVES: To evaluate prospectively the efficacy and safety of insulin glargine use for the metabolic control of type 1 diabetes mellitus (T1DM) children younger than eight years old. METHODS: Nineteen boys and 11 girls with T1DM were included. Before initiating insulin glargine, all children received intensive NPH and aspart insulins for three months. Afterwards, they were assisted for 12 more months for glargine treatment. All patients performed self blood glucose monitoring before and two hours after meals and in early morning (3:00 AM). Primary endpoints: metabolic control using A1C levels; frequency of mild hypoglycemia (capillary glycemia < 60 mg/dL); and frequency of severe hypoglycemia (loss or alteration of consciousness, seizures or need for medical intervention). RESULTS: Mean A1C at the study entry was 8.68% and after 12 months of glargine, was 8.64% (p = 0.82). Frequency of mild hypoglycemia at 3.00 AM was 1.43/3 months during the NPH period and 0.28/3 months during the glargine period (p < 0.007). Frequency of severe hypoglycemia was 0.56/3 months during the NPH period and 0.008/3 months during the glargine period (p < 0.002). CONCLUSIONS: The treatment of T1DM children with insulin glargine was considered as efficacious as with NPH. However, a better safety profile, disclosed by the lower incidence of nocturnal and severe hypoglycemia episodes, was observed for insulin glargine.
Keywords : Type 1 diabetes mellitus; insulin glargine; child; hypoglycemia.